No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Cuts Target Price to $9
Express News | Kezar Life Sciences Inc - Enters Into Amendment No. 1 to Rights Agreement
H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
HC Wainwright & Co. Reiterates Neutral on Kezar Life Sciencesto Neutral
KEZAR MARKETS ANNOUNCES RETIREMENT OF CEO WHIT CONARY & NAMES STEVE MIELE AS THE NEW CHIEF EXECUTIVE OFFICER
Express News | Kezar Life Sciences Inc: On November 13, Regains Compliance With Nasdaq’s Minimum Bid Price Requirement